I live with very advanced prostate cancer in Melbourne Australia. I am also involved in academic research, albeit not medical. PCI offers me the perfect gateway to the most up-to-date science research relevant to my situation. Plus insightful and realistic explanations and commentary. It has helped me understand the options available to me now and in the clinical trial pipeline. I attend an excellent cancer research hospital that is at the leading edge, so PCI helps me ask intelligent questions and get down to details. I will continue to trust and depend on the excellent reporting by PCI.
Great support from qualified and caring people...thank you
I got great support when i needed it most-thank you so much.
I regularly follow the prostate cancer news on the prostatecancerinfolink.net website. This is my primary means of educating myself about new developments, and is an indispensable tool for me. Mike Scott and Allen Edel are amazing, both in the time and energy they put into preparing articles, and also in responding to readers' comments!
As a seventeenth year survivor of once life-threatening prostate cancer, I find this website to be amazingly good - one of the very best I've ever used!
A core strength is the profound expertise, caring, and energy that the sitemaster employs in bringing us reports of worthwhile new studies and also discussing those studies with us.
This is my best resource in keeping up-to-date on the fast moving field of prostate cancer research and trends.
I eagerly await new articles on "The "New" Prostate Cancer Infolink. Almost daily I come away with information from outstanding reviews - objective, expert, insightful and in easily understood language - of new research papers and important news in the world of prostate cancer. This is important to me as a survivor for twelve and a half years of a challenging case, important both in dealing with my own circumstances and also in educating myself so I can help other prostate cancer patients and interact with prostate cancer advocates. I frequently relay information from the Infolink to other internet boards on which I participate and to my support and education group. A key feature of the service is the comment interaction after each article. Hot topics draw a number of responses, including my own, with balanced and thoughtful participation by the sitemaster, and frequently with posts from prominent medical professionals. This is the most valuable site I have ever used.
This website provides timely annotated reviews of the latest research, a useful forum to ask questions and a social network so one can coordinate with other patients, as well as patient information on a very wide variety of prostate cancer issues.
A most informative and timely source of information for those battling prostate cancer. I personally peruse dozens of technical info on this is the best.
Am grateful for the comprehensive, careful and clearly written advanced prostate cancer information provided by this organization.
I am extremely grateful for keeping me aware about the news and trends in prostate cancer treatments after total prostatectomy, which I had to undergo in November 2014, at the highly specialized Martini-clinic in Hamburg, Germany.
Your updates help to provide some clarity on expectations for future therapeutic measures, in case my PSA increases further.
Your comments hep to realize the controversial trends in postop treatments.
Please continue the way you work and help us all to keep us updated.
Thanks,, Peter Koerfgen, Switzerland
I find the information posted on the PCI, "New Prostate Cancer Infolink" to be timely, relevant, and above-all, well balanced. I appreciate postings with which the site master(s) disagree and I value their comments explaining their disagreement.
As a PCA patient, I received triple therapy: HDR, IGRT, and ADT. As I read the postings, I try to put myself (with that complement of treatments) into each article.
I have posted my reviews on this site in the past, and I can add that PCI continues to be the premiere non-profit for unbiased, truthful, critically constructive , and evaluative reporting on prevention, diagnosis, and treatment of prostate cancer. I would strongly encourage any person who wants to stay on top of the latest prostate cancer news to subscribe to PCI. The PCI "Sitemaster" not only attends and reports on new abstracts presented at professional medical conferences and he comments on the published results of recent clinical trials, but he personally responds to questions and comments from his subscribers. The PCI site has a link to enable a person to search for all articles published on the site by subject area . The distinguishing feature of PCI is the Sitemaster who has the scientific and medical knowledge to independently and accurately evaluate and opine on prostate cancer news stories, media releases, medical abstracts, and clinical trial results. Sitemaster and PCI have no motive other than educating and advocating for the patient. For those interested, PCI also has a social network for support where the patient can ask questions of other patients, participate in discussion threads, and communicate with Sitemaster on all topics related to prostate cancer. If you have a question about prostate cancer and you want an unbiased, accurate, and truthful answer, please visit the PCI site. I have advanced prostate cancer and have used the PCI site dozens of times and read the posts on a daily basis.
If you have prostate cancer or think you might have prostate cancer, and you want to learn about the latest developments in the diagnosis and treatment of prostate cancer, then this is the internet site you must visit. What's unique about the site is the analysis and comments of "Sitemaster", who is a professional medical communications specialist extremely knowledgeable about prostate cancer. You can also ask Sitemaster questions about your personal situation and he will promptly respond with an unbiased, informative answer. For those interested, the site also offers social networking opportunities, and links to other sites related to prostate cancer research, clinical trials, and nationally adopted diagnosis and treatment standards.